HK1153267A1 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure - Google Patents
Methods and compositions for diagnosis and prognosis of renal injury and renal failureInfo
- Publication number
- HK1153267A1 HK1153267A1 HK11107246.4A HK11107246A HK1153267A1 HK 1153267 A1 HK1153267 A1 HK 1153267A1 HK 11107246 A HK11107246 A HK 11107246A HK 1153267 A1 HK1153267 A1 HK 1153267A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- renal
- prognosis
- diagnosis
- compositions
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4745—Insulin-like growth factor binding protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/795—Porphyrin- or corrin-ring-containing peptides
- G01N2333/80—Cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9291808P | 2008-08-29 | 2008-08-29 | |
US9292108P | 2008-08-29 | 2008-08-29 | |
PCT/US2009/055460 WO2010025434A1 (fr) | 2008-08-29 | 2009-08-28 | Procédés et compositions pour le diagnostic et le pronostic de la blessure rénale et de l’insuffisance rénale |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1153267A1 true HK1153267A1 (en) | 2012-03-23 |
Family
ID=41721973
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11107246.4A HK1153267A1 (en) | 2008-08-29 | 2011-07-12 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
HK16100750.2A HK1212776A1 (zh) | 2008-08-29 | 2016-01-22 | 用於診斷和預後腎損傷和腎衰竭的方法和組合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16100750.2A HK1212776A1 (zh) | 2008-08-29 | 2016-01-22 | 用於診斷和預後腎損傷和腎衰竭的方法和組合物 |
Country Status (7)
Country | Link |
---|---|
US (2) | US9057735B2 (fr) |
EP (2) | EP2813848A3 (fr) |
JP (2) | JP5947544B2 (fr) |
CN (2) | CN105021826A (fr) |
CA (1) | CA2735590A1 (fr) |
HK (2) | HK1153267A1 (fr) |
WO (1) | WO2010025434A1 (fr) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2240781T3 (en) | 2008-01-18 | 2018-03-26 | Harvard College | METHODS FOR DETECTING DISEASE OR STATE SIGNATURES IN BODY FLUIDS |
NZ591437A (en) * | 2008-08-28 | 2013-07-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
JP5947544B2 (ja) | 2008-08-29 | 2016-07-06 | アスチュート メディカル,インコーポレイテッド | 腎損傷および腎不全の診断および予後のための方法および組成物 |
ES2836218T3 (es) * | 2008-10-21 | 2021-06-24 | Astute Medical Inc | Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal |
CA2740923A1 (fr) * | 2008-10-21 | 2010-04-29 | Astute Medical, Inc. | Procedes et compositions pour le diagnostic et le pronostic de lesion renale et d'insuffisance renale |
EP2913676A1 (fr) | 2008-11-10 | 2015-09-02 | Astute Medical, Inc. | Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale |
WO2010059996A1 (fr) * | 2008-11-22 | 2010-05-27 | Astute Medical, Inc. | Procédés et compositions pour le diagnostic et le pronostic d’une lésion rénale ou d’une insuffisance rénale |
US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EA201290056A1 (ru) | 2009-08-07 | 2012-08-30 | Астьют Медикал, Инк. | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности |
CN104793000A (zh) | 2009-11-07 | 2015-07-22 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
CA2784889C (fr) | 2009-12-20 | 2018-06-19 | Astute Medical, Inc. | Procedes et compositions pour diagnostic et pronostic d'une lesion renale et d'une insuffisance renale |
US20120156701A1 (en) * | 2009-12-20 | 2012-06-21 | Joseph Anderberg | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2011097539A1 (fr) | 2010-02-05 | 2011-08-11 | Astute Medical, Inc. | Méthodes et compositions utilisables pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale |
JP5998057B2 (ja) | 2010-02-26 | 2016-11-30 | アスチュート メディカル,インコーポレイテッド | 腎損傷および腎不全の診断と予後のための方法と組成物 |
WO2011109446A1 (fr) * | 2010-03-01 | 2011-09-09 | Astute Medical, Inc. | Méthodes et compositions pour le diagnostic et le pronostic d'une lésion rénale et de l'insuffisance rénale chez une population en service de soins intensifs non chirurgical |
ES2524082T3 (es) * | 2010-06-15 | 2014-12-04 | F.Hoffmann-La Roche Ag | Predicción y reconocimiento de la lesión renal aguda después de la cirugía |
EP2585827A4 (fr) | 2010-06-23 | 2013-12-04 | Astute Medical Inc | Méthodes et compositions pour diagnostiquer et pronostiquer une lésion rénale et une insuffisance rénale |
NZ703055A (en) | 2010-06-23 | 2016-07-29 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CA2806296A1 (fr) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Procedes de detection de maladies ou d'etats associes au rein |
AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
MX2013000917A (es) | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
SG10201505723UA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
AU2011280936A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
US10557856B2 (en) * | 2010-09-24 | 2020-02-11 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Biomarkers of renal injury |
EP2668499A4 (fr) * | 2011-01-29 | 2015-05-27 | Astute Medical Inc | Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale |
AU2012312907A1 (en) * | 2011-08-26 | 2014-03-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2788759B1 (fr) | 2011-12-08 | 2019-02-20 | Astute Medical, Inc. | Procédés et utilisations permettant de diagnostiquer une lésion des reins et une insuffisance rénale |
US20150241419A1 (en) * | 2012-08-03 | 2015-08-27 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP4105657A1 (fr) | 2013-01-17 | 2022-12-21 | Astute Medical, Inc. | Procédés et compositions pour le diagnostic et le pronostic de lésions rénales et d'insuffisance rénale |
NZ771629A (en) | 2013-03-09 | 2022-12-23 | Harry Stylli | Methods of detecting cancer |
EP2965086A4 (fr) | 2013-03-09 | 2017-02-08 | Harry Stylli | Procédés de détection du cancer de la prostate |
EP3546940B1 (fr) * | 2013-05-14 | 2021-02-17 | Metabolon, Inc. | Biomarqueurs associés à la fonction rénale et procédés les utilisant |
CN110007084B (zh) | 2013-12-03 | 2022-11-18 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
EP3693742B1 (fr) | 2014-09-11 | 2022-04-06 | Harry Stylli | Procédés pour détecter le cancer de la prostate |
WO2016164854A1 (fr) | 2015-04-09 | 2016-10-13 | Astute Medical, Inc. | Méthodes et compositions pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale |
CN106217377B (zh) * | 2015-10-14 | 2018-07-27 | 山东世纪元通智能科技有限公司 | 路径点式行走机器人的控制方法 |
JP2019523889A (ja) | 2016-06-06 | 2019-08-29 | アスチュート メディカル,インコーポレイテッド | インスリン様増殖因子結合タンパク質7およびメタロプロテアーゼ2の組織阻害剤を使用する急性腎臓傷害の管理 |
CA3049444A1 (fr) | 2017-01-12 | 2018-07-19 | Astute Medical, Inc. | Methodes et compositions destinees a l'evaluation et au traitement d'une lesion renale et d'une insuffisance renale sur la base d'une mesure du ligand chimiokine a motif c-c 14 |
CN110431422A (zh) | 2017-02-06 | 2019-11-08 | 机敏医药股份有限公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
CN106845140A (zh) * | 2017-03-01 | 2017-06-13 | 重庆工商大学 | 一种基于尿比重和尿量监测的肾衰竭预警方法及系统 |
US11263275B1 (en) * | 2017-04-03 | 2022-03-01 | Massachusetts Mutual Life Insurance Company | Systems, devices, and methods for parallelized data structure processing |
US20180322956A1 (en) | 2017-05-05 | 2018-11-08 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Time Window-Based Platform for the Rapid Stratification of Blunt Trauma Patients into Distinct Outcome Cohorts |
US11435364B2 (en) | 2018-05-24 | 2022-09-06 | Renibus Therapeutics, Inc. | Methods of treating patients at risk for renal injury and renal failure |
WO2020064995A1 (fr) * | 2018-09-28 | 2020-04-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Utilisation de biomarqueurs représentant des voies cardiaques, vasculaires et inflammatoires permettant la prédiction d'une lésion rénale aiguë chez des patients atteints de diabète de type 2 |
CN109754878B (zh) * | 2018-11-30 | 2023-06-20 | 平安科技(深圳)有限公司 | 慢性肾病筛查方法、装置、设备及存储介质 |
CN114783607B (zh) * | 2022-05-10 | 2023-06-23 | 中南大学湘雅医院 | 一种手术输血风险预测模型及其网络计算器的构建方法 |
CN118216609B (zh) * | 2024-05-24 | 2024-08-09 | 潍坊新希望六和饲料科技有限公司 | 一种多肽在降低羔羊断奶应激反应的饲料添加剂中的应用 |
Family Cites Families (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1429031A1 (ru) | 1986-06-20 | 1988-10-07 | Калининский Государственный Медицинский Институт | Способ дифференциальной диагностики гломерулонефрита и пиелонефрита |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
WO1992005282A1 (fr) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Anticorps contre des complexes de recepteurs de ligand et des ligands ainsi que leur utilite dans des dosages ligands-recepteurs |
US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
JPH06506688A (ja) | 1991-04-10 | 1994-07-28 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | クロストークインヒビターおよびその使用 |
ES2150915T3 (es) | 1991-04-12 | 2000-12-16 | Biosite Diagnostics Inc | Nuevos conjugados y dosificados destinados para la deteccion simultanea de ligandos multiples. |
US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
JP4602482B2 (ja) | 1996-05-24 | 2010-12-22 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 組織再生のモジュレーター |
US5753455A (en) | 1996-09-03 | 1998-05-19 | Bayer Corporation | Method for the detection of lysozyme using a protein error indicator dye in conjunction with an alkane sulfonic acid |
US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
WO1998055508A2 (fr) | 1997-06-03 | 1998-12-10 | Sagami Chemical Research Center | Proteines humaines ayant des domaines transmembranaires et adn codant ces proteines |
US20060223077A1 (en) | 1997-06-06 | 2006-10-05 | Human Genome Sciences, Inc. | 207 human secreted proteins |
US6218122B1 (en) | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
US6958147B1 (en) | 1998-10-26 | 2005-10-25 | Licentia Ltd | Use of VEGF-C to prevent restenosis |
CN1331801A (zh) | 1998-12-21 | 2002-01-16 | 莫纳什大学 | 肾病检测及治疗 |
ATE365327T1 (de) * | 1999-11-08 | 2007-07-15 | Eisai Co Ltd | Verfahren zum nachweis von zelltod mittels cytochrom c. |
RU2180965C1 (ru) | 2000-07-03 | 2002-03-27 | Габбасова Наталья Вадимовна | Способ дифференциальной диагностики заболеваний почек |
EP1405072A2 (fr) | 2000-12-29 | 2004-04-07 | Oxford GlycoSciences (UK) Limited | Proteines, genes et leur utilisation pour le diagnostic et le traitement de la reponse renale |
US20060088823A1 (en) | 2001-03-29 | 2006-04-27 | Brian Haab | Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification |
JP3896303B2 (ja) * | 2001-05-09 | 2007-03-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | チトクロムc測定によるsirsにおける多臓器不全の検査試薬 |
US20070015146A1 (en) * | 2001-05-22 | 2007-01-18 | Gene Logic, Inc. | Molecular nephrotoxicology modeling |
US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US20030003588A1 (en) | 2001-06-28 | 2003-01-02 | Comper Wayne D. | Method for kidney disease detection by protein profiling |
KR20040025931A (ko) * | 2001-07-12 | 2004-03-26 | 교와 메덱스 가부시키가이샤 | 변성 리포단백질의 정량법, 변성 리포단백질의 정량용시약, 순환기 질환의 검출방법 및 순환기 질환의 검출시약 |
HUP0400659A3 (en) | 2001-07-24 | 2005-06-28 | Zhu Zhou Woodbridge | Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
US6784154B2 (en) | 2001-11-01 | 2004-08-31 | University Of Utah Research Foundation | Method of use of erythropoietin to treat ischemic acute renal failure |
US8404229B2 (en) | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
GB0130557D0 (en) | 2001-12-20 | 2002-02-06 | Serono Internat S A | Proteins |
CA2478288A1 (fr) | 2002-03-07 | 2003-09-12 | Adrian Woolfson | Empreintes digitales de scd |
AU2003214604A1 (en) | 2002-03-21 | 2003-10-08 | Hadasit Medical Research Services And Development Ltd. | Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same |
US7138230B2 (en) | 2002-12-06 | 2006-11-21 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
US7138229B2 (en) | 2002-12-06 | 2006-11-21 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
AU2003281287A1 (en) | 2002-07-04 | 2004-01-23 | Oxford Glycosciences (Uk) Ltd | Toxicity markers |
US6941172B2 (en) | 2002-11-18 | 2005-09-06 | Zvi Nachum | Method and device for restoring kidney function using electromagnetic stimulation |
US20060063156A1 (en) | 2002-12-06 | 2006-03-23 | Willman Cheryl L | Outcome prediction and risk classification in childhood leukemia |
CN1791797A (zh) | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
AU2004229501B2 (en) | 2003-04-11 | 2011-08-18 | Medimmune, Llc | Recombinant IL-9 antibodies and uses thereof |
WO2005002416A2 (fr) | 2003-06-04 | 2005-01-13 | Joslin Diabetes Center, Inc. | Predicteurs de nephropathie |
US20050148029A1 (en) | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
GB0329288D0 (en) | 2003-12-18 | 2004-01-21 | Inverness Medical Switzerland | Monitoring method and apparatus |
EP1727564A1 (fr) | 2004-03-17 | 2006-12-06 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Cd44 comme cible pour la reduction/prevention des lesions consecutives a la perfusion ischemique |
JP2007535324A (ja) | 2004-04-26 | 2007-12-06 | チルドレンズ メディカル センター コーポレーション | 疾患検出のための血小板バイオマーカー |
US20050272101A1 (en) | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
US7588892B2 (en) | 2004-07-19 | 2009-09-15 | Entelos, Inc. | Reagent sets and gene signatures for renal tubule injury |
US20080038192A1 (en) | 2004-07-19 | 2008-02-14 | Neurochem Inc. | Diagnostic Methods Of Multiple Organ Amyloidosis |
US8108149B2 (en) * | 2004-08-30 | 2012-01-31 | Tercica, Inc. | Method and device for diagnosing and treating insulin-like growth factor deficiency disorders |
US7141382B1 (en) | 2004-10-12 | 2006-11-28 | Parikh Chirag R | Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality |
WO2006083986A2 (fr) | 2005-02-01 | 2006-08-10 | Government Of The U.S.A, As Represented By The Secretary Department Of Health & Human Services | Biomarqueurs de statut tissulaire |
EP1869213A4 (fr) | 2005-03-14 | 2008-05-14 | Univ Leland Stanford Junior | Procedes et compositions permettant d'evaluer la survie d'un greffon chez un destinataire d'une transplantation d'organe solide |
US7608413B1 (en) | 2005-03-25 | 2009-10-27 | Celera Corporation | Kidney disease targets and uses thereof |
US20070037232A1 (en) | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
NZ562928A (en) * | 2005-04-18 | 2011-01-28 | Mitomics Inc | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
US20070087387A1 (en) | 2005-04-21 | 2007-04-19 | Prasad Devarajan | Method for the Early Detection of Renal Disease Using Proteomics |
CA2614935A1 (fr) | 2005-07-21 | 2007-02-01 | The Johns Hopkins University | Insuffisance renale aigue |
US7759077B2 (en) | 2005-08-02 | 2010-07-20 | Shariat Shahrokh F | Soluble fas urinary marker for the detection of bladder transitional cell carcinoma |
EP1757940A1 (fr) | 2005-08-26 | 2007-02-28 | Cézanne S.A.S. | In-vitro méthode pour la diagnose et surveillance du carcinome cellulaire renal en utilisant MMP-7 comme biomarqueur humoral |
JP2009510478A (ja) | 2005-10-03 | 2009-03-12 | バイオサイト インコーポレイテッド | 全身性炎症反応症候群の診断および/または予後診断のための方法および組成物 |
US20080090304A1 (en) * | 2006-10-13 | 2008-04-17 | Barasch Jonathan Matthew | Diagnosis and monitoring of chronic renal disease using ngal |
US8329408B2 (en) | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
US10716749B2 (en) | 2005-11-03 | 2020-07-21 | Palo Alto Investors | Methods and compositions for treating a renal disease condition in a subject |
US20080133141A1 (en) | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
TW200726845A (en) | 2006-01-02 | 2007-07-16 | Nat Defense Medical Ct | Biomarker molecular of renal illness and detecting method for the same |
GB0605217D0 (en) | 2006-03-15 | 2006-04-26 | Novartis Ag | Method and compositions for assessing acute rejection |
GB0606776D0 (en) | 2006-04-03 | 2006-05-10 | Novartis Pharma Ag | Predictive biomarkers for chronic allograft nephropathy |
US7662578B2 (en) | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
US20080038269A1 (en) | 2006-05-25 | 2008-02-14 | Mount Sinai Hospital | Methods for detecting and treating kidney disease |
WO2008084331A2 (fr) | 2006-06-21 | 2008-07-17 | Hopitaux Universitaires De Geneve | Biomarqeurs pour des troubles rénaux |
WO2008005375A2 (fr) | 2006-06-30 | 2008-01-10 | Merck & Co., Inc. | Biomarqueurs de la néphrotoxicité |
WO2008009132A1 (fr) | 2006-07-21 | 2008-01-24 | The Governors Of The University Of Alberta | Rejet tissulaire |
GB0617429D0 (en) | 2006-09-05 | 2006-10-18 | Electrophoretics Ltd | Markers of renal transplant rejection and renal damage |
US20080206794A1 (en) | 2006-09-15 | 2008-08-28 | Renovar Incorporated | Systems And Methods For Characterizing Contrast Induced-Nephropathy |
WO2008060607A2 (fr) | 2006-11-14 | 2008-05-22 | Biosite Incorporated | Procédés et compositions permettant de surveiller et de prévoir les risques du syndrome cardio-rénal |
EP2064550B1 (fr) * | 2006-12-08 | 2015-02-25 | The Children's Hospital Of Philadelphia | L'utilisation de prrg4 dans des procedes de diagnostic de tumeur |
JP5162751B2 (ja) * | 2007-01-17 | 2013-03-13 | 国立大学法人 宮崎大学 | 急性腎不全の検出方法 |
GB0701626D0 (en) * | 2007-01-22 | 2007-03-07 | Cambridge Entpr Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
EP1952823A1 (fr) * | 2007-01-30 | 2008-08-06 | AM-Pharma B.V. | Utilisation de phosphatase d'alcaline dans le traitement de la fonction rénale réduite |
WO2008104803A2 (fr) | 2007-02-26 | 2008-09-04 | Oxford Genome Sciences (Uk) Limited | Protéines |
US8221995B2 (en) | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
EP2479570A3 (fr) | 2007-03-26 | 2012-09-26 | Novartis AG | Biomarqueurs de sécurité rénale prédictive et signatures de biomarqueur pour surveiller la fonction rénale |
WO2008122670A2 (fr) | 2007-04-10 | 2008-10-16 | Integragen | Gène tnfrsf10b de susceptibilité au diabète chez l'homme |
US8080394B2 (en) * | 2007-04-27 | 2011-12-20 | Brigham And Women's Hospital | Method for determining predisposition to pulmonary infection |
US9091695B2 (en) | 2007-06-01 | 2015-07-28 | Laboratory Corporation Of America Holdings | Methods and systems for quantification of peptides and other analytes |
US20100184110A1 (en) | 2007-06-06 | 2010-07-22 | Siemens Healthcare Diagnostics Inc. | Predictive diagnostics for kidney disease |
US20090047689A1 (en) | 2007-06-20 | 2009-02-19 | John Kolman | Autoantigen biomarkers for early diagnosis of lung adenocarcinoma |
US20100267041A1 (en) | 2007-09-14 | 2010-10-21 | Predictive Biosciences, Inc. | Serial analysis of biomarkers for disease diagnosis |
US8039227B2 (en) | 2007-09-20 | 2011-10-18 | University Of Louisville Research Foundation, Inc. | Peptide biomarkers predictive of renal function decline and kidney disease |
WO2009038742A2 (fr) | 2007-09-20 | 2009-03-26 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Procédé pour estimer le risque d'une lésion rénale aiguë |
US8003333B2 (en) | 2007-09-28 | 2011-08-23 | Mayo Foundation For Medical Education And Research | Serum biomarkers for early detection of acute cellular rejection |
US20110111427A1 (en) | 2008-02-29 | 2011-05-12 | Kenji Kadomatsu | Biomarker for the estimation of acute renal disorder and prognosis of the disorder, and use of the biomarker |
US20090298106A1 (en) | 2008-05-30 | 2009-12-03 | Therapeutic Monitoring Services, L.L.C. | Methods for Monitoring Immunosuppressant Drug Levels, Renal Function, and Hepatic Function Using Small Volume Samples |
US8241861B1 (en) * | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
EP2149613A1 (fr) * | 2008-07-28 | 2010-02-03 | Greenwood Genetic Center, Inc. | Procédés pour déterminer la dérégulation de la méthylation de gènes du chromosome X exprimés par le cerveau afin de diagnostiquer des troubles du spectre autistique |
WO2010022210A2 (fr) | 2008-08-21 | 2010-02-25 | Pxbiosciences Llc | Diagnostic et surveillance de l’insuffisance rénale au moyen de biomarqueurs peptidiques |
NZ591437A (en) | 2008-08-28 | 2013-07-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
JP5947544B2 (ja) | 2008-08-29 | 2016-07-06 | アスチュート メディカル,インコーポレイテッド | 腎損傷および腎不全の診断および予後のための方法および組成物 |
US8501489B2 (en) | 2008-09-26 | 2013-08-06 | University of Pittsburgh—of the Commonwealth System of Higher Education | Urinary biomarkers to predict long-term dialysis |
CA2740923A1 (fr) | 2008-10-21 | 2010-04-29 | Astute Medical, Inc. | Procedes et compositions pour le diagnostic et le pronostic de lesion renale et d'insuffisance renale |
ES2836218T3 (es) | 2008-10-21 | 2021-06-24 | Astute Medical Inc | Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal |
EP2913676A1 (fr) | 2008-11-10 | 2015-09-02 | Astute Medical, Inc. | Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale |
WO2010091231A1 (fr) | 2009-02-06 | 2010-08-12 | Astute Medical, Inc. | Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et de l'insuffisance rénale |
CA2751435A1 (fr) | 2009-02-06 | 2010-08-12 | Astute Medical, Inc. | Procedes et compositions pour le diagnostic et le pronostic d'une lesion renale et d'une insuffisance renale |
US9229010B2 (en) | 2009-02-06 | 2016-01-05 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2427496A4 (fr) | 2009-04-03 | 2013-05-15 | Vegenics Pty Ltd | Anticorps anti-vegf-d |
WO2010128158A1 (fr) | 2009-05-08 | 2010-11-11 | Novartis Ag | Biomarqueurs diagnostiques pour des troubles fibrotiques |
WO2011017684A1 (fr) | 2009-08-07 | 2011-02-10 | Rules-Based Medicine, Inc. | Méthodes et dispositifs permettant de détecter une néphropathie diabétique et des affections associées |
EP2480882A4 (fr) | 2009-09-21 | 2013-07-10 | Astute Medical Inc | Procedes et compositions de diagnostic et de pronostic de lesions et d'insuffisances renales |
CA2784889C (fr) | 2009-12-20 | 2018-06-19 | Astute Medical, Inc. | Procedes et compositions pour diagnostic et pronostic d'une lesion renale et d'une insuffisance renale |
US20130035290A1 (en) | 2011-05-17 | 2013-02-07 | Yale University | Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
-
2009
- 2009-08-28 JP JP2011525262A patent/JP5947544B2/ja not_active Expired - Fee Related
- 2009-08-28 CN CN201510400587.XA patent/CN105021826A/zh active Pending
- 2009-08-28 CN CN200980140694.6A patent/CN102187219B/zh not_active Expired - Fee Related
- 2009-08-28 EP EP14176863.0A patent/EP2813848A3/fr not_active Withdrawn
- 2009-08-28 EP EP09810705.5A patent/EP2324354B1/fr not_active Not-in-force
- 2009-08-28 CA CA2735590A patent/CA2735590A1/fr not_active Abandoned
- 2009-08-28 WO PCT/US2009/055460 patent/WO2010025434A1/fr active Application Filing
- 2009-08-28 US US13/061,446 patent/US9057735B2/en not_active Expired - Fee Related
-
2011
- 2011-07-12 HK HK11107246.4A patent/HK1153267A1/xx not_active IP Right Cessation
-
2015
- 2015-06-14 US US14/738,904 patent/US9417250B2/en not_active Expired - Fee Related
- 2015-11-30 JP JP2015233652A patent/JP2016053587A/ja active Pending
-
2016
- 2016-01-22 HK HK16100750.2A patent/HK1212776A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN102187219B (zh) | 2015-08-05 |
US9057735B2 (en) | 2015-06-16 |
JP2012501457A (ja) | 2012-01-19 |
CN105021826A (zh) | 2015-11-04 |
JP5947544B2 (ja) | 2016-07-06 |
EP2324354A1 (fr) | 2011-05-25 |
EP2324354A4 (fr) | 2012-03-21 |
EP2813848A3 (fr) | 2015-03-11 |
EP2813848A2 (fr) | 2014-12-17 |
JP2016053587A (ja) | 2016-04-14 |
CN102187219A (zh) | 2011-09-14 |
CA2735590A1 (fr) | 2010-03-04 |
US20110174062A1 (en) | 2011-07-21 |
EP2324354B1 (fr) | 2014-07-16 |
US20150285824A1 (en) | 2015-10-08 |
WO2010025434A1 (fr) | 2010-03-04 |
US9417250B2 (en) | 2016-08-16 |
HK1212776A1 (zh) | 2016-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212776A1 (zh) | 用於診斷和預後腎損傷和腎衰竭的方法和組合物 | |
HK1213320A1 (zh) | 用於診斷和預後腎損傷和腎衰竭的方法和組合物 | |
HK1203619A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1199929A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1199931A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1211082A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1159755A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
EP2480882A4 (fr) | Procedes et compositions de diagnostic et de pronostic de lesions et d'insuffisances renales | |
HK1208074A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1167455A1 (zh) | 用於腎損傷和腎衰竭的診斷及預後方法和組合物 | |
HK1214864A1 (zh) | 用於腎損傷和腎衰竭的診斷及預後的方法和組合物 | |
EP2539712A4 (fr) | Procédés et compositions pour diagnostic et pronostic de lésion rénale et d'insuffisance rénale | |
HK1200218A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
EP2531620A4 (fr) | Méthodes et compositions utilisables pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale | |
HK1167888A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1211084A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
HK1212774A1 (zh) | 用於腎損傷和腎衰竭的診斷及預後方法和組合物 | |
EP2462446A4 (fr) | Méthodes et compositions utilisables à des fins de diagnostic et de pronostic en cas de lésion ou d'insuffisance rénale | |
EP2531622A4 (fr) | Procédés et compositions pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale | |
EP2585825A4 (fr) | Méthodes et compositions pour diagnostiquer et pronostiquer une lésion rénale et une insuffisance rénale | |
EP2531621A4 (fr) | Méthodes et compositions utilisables pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale | |
EP2593794A4 (fr) | Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale | |
HK1197298A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180823 |